Insider · CIK 0001377202

Sharp Shalini

Reports to the SEC for 12 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001377202

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-14	IAMIambic Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.3K sh	—	—	20,300
2026-06-26	SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2026-06-12	OGNOrganon & Co. · Phantom StockA Award	Director	AAward	+17.9K sh	$13.44	+$240K	81,495.885
2026-06-11	ONCBeOne Medicines Ltd.A Award	Director	AAward	+19K sh	—	—	38,116
2026-05-27	NBIXNEUROCRINE BIOSCIENCES INC · Restriced Stock UnitA Award	Director	AAward	+2,567 sh	—	—	2,567
2026-05-21	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,659 sh	—	—	0
2026-05-21	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+1,659 sh	—	—	4,088
2025-06-17	SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.6K sh	—	—	16,623
2025-06-13	OGNOrganon & Co. · Phantom StockA Award	Director	AAward	+23.9K sh	$10.04	+$240K	63,054.148
2025-05-22	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+1,435 sh	—	—	2,429
2025-05-22	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,435 sh	—	—	0
2025-05-21	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Director	AAward	+1,659 sh	—	—	1,659
2025-05-21	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+22.8K sh	—	—	22,750
2025-05-21	ONCBeOne Medicines Ltd.A Award	Director	AAward	+11K sh	—	—	19,136
2025-05-21	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionA Award	Director	AAward	+3,305 sh	—	—	3,305
2024-09-30	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+17.2K sh	—	—	17,238
2024-09-30	ONCBeOne Medicines Ltd.A Award	Director	AAward	+8,151 sh	—	—	8,151
2024-06-07	OGNOrganon & Co. · Phantom StockA Award	Director	AAward	+9,638.554 sh	$20.75	+$200K	36,783.9
2024-05-22	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Director	AAward	+1,435 sh	—	—	1,435
2024-05-22	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionA Award	Director	AAward	+2,982 sh	—	—	2,982
2024-05-17	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,100 sh	—	—	0
2024-05-17	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director	SSale	−1,106 sh	$141.90	−$157K	994
2024-05-17	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+2,100 sh	—	—	2,100
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,252 sh	—	—	6,808
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−4,162 sh	—	—	12,060
2024-01-23	Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−7,520 sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,808 sh	—	—	0
2023-12-29	Mirati Therapeutics, Inc.A Award	Director	AAward	+6,808 sh	$58.75	+$400K	16,222
2023-06-09	OGNOrganon & Co. · Phantom StockA Award	Director	AAward	+10.1K sh	$19.83	+$200K	25,594
2023-05-17	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionA Award	Director	AAward	+4,290 sh	—	—	4,290
2023-05-17	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Director	AAward	+2,100 sh	—	—	2,100
2023-01-20	Mirati Therapeutics, Inc.A Award	Director	AAward	+4,444 sh	—	—	9,414
2023-01-20	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award	Director	AAward	+7,520 sh	—	—	7,520
2022-06-10	OGNOrganon & Co. · Phantom StockA Award	Director	AAward	+5,640 sh	$35.46	+$200K	14,935
2022-06-06	STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2022-05-18	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionA Award	Director	AAward	+9,724 sh	—	—	9,724
2022-01-14	Mirati Therapeutics, Inc.A Award	Director	AAward	+2,546 sh	—	—	4,970
2022-01-14	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award	Director	AAward	+3,688 sh	—	—	3,688
2021-06-04	OGNOrganon & Co. · Phantom StockA Award	Director	AAward	+9,061 sh	$36.05	+$327K	9,061
2021-06-03	STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2021-05-19	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionA Award	Director	AAward	+8,833 sh	—	—	8,833
2021-05-10	DTILPRECISION BIOSCIENCES INC · Stock Option (Right to Buy)A Award	Director	AAward	+32.8K sh	—	—	32,800
2021-03-26	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award	Director	AAward	+3,523 sh	—	—	3,523
2021-03-26	Mirati Therapeutics, Inc.A Award	Director	AAward	+2,424 sh	—	—	2,424
2021-02-10	NUVBNuvation Bio Inc. · Class B Common StockM Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2021-02-10	NUVBNuvation Bio Inc.A Award	Director	AAward	+10K sh	$10.00	+$100K	35,000
2021-02-10	NUVBNuvation Bio Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	—	—	25,000
2020-10-14	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP, Finance	SSale	−375 sh	$87.99	−$33K	97,812
2020-08-17	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP, Finance	SSale	−7,188 sh	$88.38	−$635K	98,187
2020-08-17	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP, Finance	SSale	−500 sh	$88.38	−$44.2K	98,187

Recent filings

Accepted (ET)
Oct 16 16:224
Sharp Shalini0001377202-26-000012
SEC(opens sec.gov)
Jun 304
Sharp Shalini0001193125-26-291055
SEC(opens sec.gov)
Jun 154
Sharp Shalini0001377202-26-000007
SEC(opens sec.gov)
Jun 154
Sharp Shalini0001628280-26-043256
SEC(opens sec.gov)
May 294
Sharp Shalini0001377202-26-000006
SEC(opens sec.gov)
May 214
Sharp Shalini0001377202-26-000004
SEC(opens sec.gov)
Jun 204
Sharp Shalini0000950170-25-088622
SEC(opens sec.gov)
Jun 164
Sharp Shalini0001821825-25-000055
SEC(opens sec.gov)
May 224
Sharp Shalini0000914475-25-000131
SEC(opens sec.gov)
May 224
Sharp Shalini0001651308-25-000090
SEC(opens sec.gov)
Oct 24
Sharp Shalini0001651308-24-000131
SEC(opens sec.gov)
Jun 114
Sharp Shalini0001821825-24-000079
SEC(opens sec.gov)
May 234
Sharp Shalini0000914475-24-000154
SEC(opens sec.gov)

Companies

Address

C/O IAMBIC THERAPEUTICS, INC. 5627 OBERLIN DRIVE, SUITE 120

SAN DIEGO, CA, 92121